"The diabetes market is expected to see incredible growth in the near future, at about 70 percent by 2015," said Shaylyn Pike, lead author of the report. "Our study points out key areas of opportunity for pharma companies, as well as research areas to avoid -- information especially helpful as me-too drugs continue to fall out of favor."

The report is organized into profiles for individual brands and drug manufacturers.

Brand Profiles detail a product's competitive and strategic positioning, market opportunities, and patent and litigation data. Profiles include the following information:

-- Drug's current and projected competitive strength -- Current/projected sales position within its class -- Sales projection charts through 2015 -- Assessment of competition -- Materiality charts -- Clinical trial information -- Patent expirations

Company Profiles show breakdowns for 10 companies that have established antidiabetes franchises or exciting development pipelines. Profiles contain:

-- Diabetes market position/ranking -- Market forecast -- Strengths analysis -- Growth areas analysis -- Market-changing opportunities analysis -- Key products breakdown

SOURCE: Cutting Edge Information